...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM thoughts
5
Nov 28, 2017 03:59PM
3
Nov 28, 2017 06:38PM

Good question about whether the financing is ZCC or ZEL. Yes, I have sent questions in advance of Resverlogix corporate updates or AGMs before. I will do again for Resverlogix and Zenith no later than end of week.

BDAZ

3
Nov 29, 2017 10:12AM
Share
New Message
Please login to post a reply